Advertisement
UK markets close in 5 hours 46 minutes
  • FTSE 100

    8,357.59
    +3.54 (+0.04%)
     
  • FTSE 250

    20,477.35
    -14.64 (-0.07%)
     
  • AIM

    781.44
    +1.61 (+0.21%)
     
  • GBP/EUR

    1.1634
    +0.0012 (+0.10%)
     
  • GBP/USD

    1.2485
    -0.0013 (-0.10%)
     
  • Bitcoin GBP

    48,915.59
    -850.00 (-1.71%)
     
  • CMC Crypto 200

    1,318.20
    +18.10 (+1.39%)
     
  • S&P 500

    5,187.67
    -0.03 (-0.00%)
     
  • DOW

    39,056.39
    +172.13 (+0.44%)
     
  • CRUDE OIL

    79.43
    +0.44 (+0.56%)
     
  • GOLD FUTURES

    2,315.90
    -6.40 (-0.28%)
     
  • NIKKEI 225

    38,073.98
    -128.39 (-0.34%)
     
  • HANG SENG

    18,537.81
    +223.95 (+1.22%)
     
  • DAX

    18,539.37
    +40.99 (+0.22%)
     
  • CAC 40

    8,115.24
    -16.17 (-0.20%)
     

This FDA Nod Is a Game Changer for Patients: Could It Equal Billions for Vertex Pharmaceuticals?

This FDA Nod Is a Game Changer for Patients: Could It Equal Billions for Vertex Pharmaceuticals?

Vertex Pharmaceuticals (NASDAQ: VRTX) is already a rock star in the world of cystic fibrosis (CF) treatment. The company's drugs have been life-changing for children and adults living with the disease. It's also helped the company build up more than $11 billion in cash to support development of new CF drugs and candidates in other areas.